Houston Car Accident Lawyers
The development of Risperdal gynecomastia can be an overwhelming and embarrassing experience for a young man. Gynecomastia refers to a condition known as the development of male breasts.
Many men who took this popular anti-psychotic medication say they were never warned about the risks of Risperdal gynecomastia. Recent studies have identified that Risperdal may be linked to gynecomastia. Some of these men have developed significant breast tissue that could only be removed with surgery.
The psychological toll of a side effect can be made much worse in cases in which severe measures must be used to reverse that symptom or side effect. People who have developed gynecomastia, for example, likely want to eradicate this condition as soon as possible.
When surgical intervention is required, however, it may be difficult for a patient to reverse the condition in a timely fashion. This can lead to other damages ultimately named in a lawsuit against the manufacturer. The use of a medication may come with some minor side effects, but patients should always be aware of the risks when starting to use a new medicine.
Risperdal gynecomastia has been linked to a higher level of prolactin in the human body. Prolactin is a hormone that stimulates the production of milk which is typically only found in nursing mothers.
Elevated prolactin levels such as those related to Risperdal gynecomastia can cause breast growth, breast budding and milk production in young men and boys. Those men who have come forward to file lawsuits regarding the development of Risperdal gynecomastia claim that this side effect was never listed as a possible complication of the drug.
Risperdal or its generic form of risperidone is an FDA approved medication, prescribed to treat bipolar disorder and schizophrenia. It has also been approved for use with children as young as five due to irritability caused by autism.
Recent Risperdal studies indicate that nearly 90 percent of the patients taking the medication between the ages of five and 17 had higher levels of prolactin within two months after starting the drug. In another study, more than two percent of participants developed Risperdal gynecomastia.
Scientists currently believe that Risperidone works by blocking the neurotransmitter dopamine, which causes the pituitary gland to release more prolactin.
Although Risperdal gynecomastia may go away after a person discontinues their use of that medication, some cases cannot resolve even when the drug usage is stopped.
In these situations, the patient may have to go through gynecomastia surgery to take off the excess breast tissue or liposuction.
These come with additional risks of infection and complication. As a result, young men and boys have come forward to file lawsuits based on the development of Risperdal gynecomastia, arguing that the manufacturer knew about these risks and failed to warn the public and the medical community about the dangers.
Anyone who has developed Risperdal gynecomastia may have grounds for a lawsuit and should consult directly with the attorneys at McDonald Worley who are currently investigating claims of this type. Fill out the form on this page to receive a free case review.